Delhi agrees to Ayushman Bharat, to sign MoU soon

The Delhi government has decided to participate in the Centre’s health insurance scheme, Ayushman Bharat-National Health Protection Mission (ABNHPM), and is likely to sign an agreement next week.

The decision follows months of uncertainty over whether the Arvind Kejriwal-led Aam Aadmi Party government, which has been at loggerheads with the Centre over powers of governance, would implement the scheme as it had asked the Centre to extend funding to even those people who were not eligible as per the Socio Economic Caste Census (SECC). “Delhi told us (on Friday) that it wants to sign a memorandum of understanding (MoU) on June 29,” said Indu Bhushan, CEO, AB-NHPM.

Upon implementation, the scheme is expected to provide Rs 5 lakh health cover each to around six lakh families in Delhi, a senior official told ETon condition of anonymity. Delhi currently does not have any health insurance scheme.

Delhi gave an in-principle approval on Thursday but expressed concerns over using SECC to identify beneficiaries, as this would mean that less than 25% of the population would be covered under the insurance scheme, the official said.

The Kejriwal government instead asked the Centre to use food security ration card data to identify beneficiaries.

  • Related Posts

    MNCs seek restart of refurbished medical device imports

    New Delhi, August 19, 2025 — Global med-tech companies have urged the Centre to allow refurbished medical device imports again and include medical devices in India’s repair-services push. The request…

    Kerala’s Disease Surge Tied to Poor Hygiene and Climate Stress

    Thiruvananthapuram, August 19, 2025 — Kerala is seeing a sharp rise in communicable diseases as poor sanitation, stagnant water, and changing weather patterns create ideal conditions for outbreaks. Public-health experts…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states